Skip to main content
Log in

Xerostomia health-related quality of life: NRG oncology RTOG 0537

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this secondary analysis was to determine change in overall health-related quality of life (HRQOL) based on patient data obtained from NRG Oncology RTOG 0537 as measured by the RTOG-modified University of Washington Head and Neck Symptom Score (RM-UWHNSS).

Methods

A multi-site prospective randomized clinical trial design stratified 137 patients with post-radiation therapy xerostomia according to prior pilocarpine (PC) treatment and time after radiation therapy and/or chemotherapy and randomized patients into two groups. Patients were assigned to acupuncture or PC. Twenty-four sessions of acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) were administered over 12 weeks, or oral PC (5 mg) three times daily over the same 12 weeks. The RM-UWHNSS was administered at baseline and at 4, 6, 9, and 15 months after the date of randomization.

Results

There were no between-arm differences in change scores on the RM-UWHNSS in the individual items, total score, or factor scores. For statistical modeling, race and time were significant for all outcomes (total and factor scores), while treatment arm was not significant. The ALTENS arm showed greater yet nonsignificant improvement in outcomes compared to the PC arm.

Conclusion

Although no significant treatment differences were seen in this trial, patients receiving ALTENS consistently had lower scores, indicating better function, as compared to those receiving PC. Radiation-induced xerostomia improved over time for all patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dirix, P., Nuytx, S., Vander Poorten, V., Delaere, P., & Van den Bogaert, W. (2008). The influence of xerostomia after radiotherapy on quality of life: Results of a questionnaire in head and neck cancer. Supportive Care in Cancer, 16(2), 171–179.

    Article  PubMed  Google Scholar 

  2. Scarantino, C. L. F., Swann, R. S., et al. (2006). Effect of pilocarpine during radiation therapy: Results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. Journal of Support Oncology, 4(5), 252–258.

    CAS  Google Scholar 

  3. Wong, R., Jones, G., Sagar, S., Babjak, A., & Whelan, T. (2003). A phase I–II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. International Journal of Radiation Oncology Biology Physics, 57(2), 472–480.

    Article  Google Scholar 

  4. Wong, R. K. W., Deshmukh, S., Wyatt, G., et al. (2015). RTOG 0537 Phase 2/3 study comparing Acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating early radiation-induced xerostomia: Phase 3 preliminary analysis. International Journal of Radiation Oncology Biology Physics, 92(2), 220–227.

    Article  CAS  Google Scholar 

  5. Wong, R., James, J., Sagar, S., et al. (2012). Phase 2 results from Radiation Therapy Oncology Group Study 0537: A phase 2/3 study comparing acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating early radiation-induced xerostomia. Cancer, 118(17), 4244–4252.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wong, R., Deshmukh, S., Wyatt, G., et al. (2013). RTOG 0537 phase 2/3 study comparing acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) versus pilocarpine (PC) in treating early radiation-induced xerostomia (RIX): Phase 3 preliminary analysis. International Journal of Radiation Oncology Biology Physics, 87(2), S116.

    Article  Google Scholar 

  7. Zelen, M. (1974). The randomization and stratification of patients to clinical trials. Journal of Chronic Disease, 27(7–8), 365–375.

    Article  CAS  Google Scholar 

  8. Hassan, S., & Weymuller, E, Jr. (1993). Assessment of quality of life in head and neck cancer patients. Head and Neck, 15(6), 485–496.

    Article  CAS  PubMed  Google Scholar 

  9. Weymuller, E, Jr, Alsarraf, R., Yueh, B., Deleyiannis, F., & Coltera, M. (2001). Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Archives of Otolaryngology: Head and Neck Surgery, 127(5), 489–493.

    Article  Google Scholar 

  10. Pomeranz B, Niznik G. Codetron (1987). A new electrotherapy device overcomes the habituation problems of conventional TENS devices. American Journal of Electromedicine, 2, 22–26.

    Google Scholar 

  11. Dirix, P., Nuyts, S., & Van den Bogaert, W. (2006). Radiation-induced xerostomia in patients with head and neck cancer. Cancer, 107, 2525–2534.

    Article  PubMed  Google Scholar 

  12. Hoffman, K., Pugh, S., James, J., et al. (2014). The impact of concurrent granulocyte macrophage-colony stimulating factor on quality of life in head and neck cancer patients: Results of the randomized placebo-controlled Radiation Therapy Oncology Group 9901 trial. Quality of Life Research, 23, 1841–1858.

    Article  PubMed  PubMed Central  Google Scholar 

  13. SAS Software, Version 9.2 of the SAS system for windows. Copyright 20022003 SAS Institute Inc., Cary, NC, USA.

  14. Kannan, V., Bapsy, P., Anantha, N., Doval, D., Vaithianathan, H., & Benumathy, G. (1997). Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. International Journal of Radiation Oncology Biology Physics, 37(5), 1005–1010.

    Article  CAS  Google Scholar 

  15. Chi, K., Chen, C., Chan, W., Chow, K., Chen, S., & Yen, S. (1995). Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. Journal of Clinical Oncology, 13(10), 2620–2628.

    CAS  PubMed  Google Scholar 

  16. Sprinzl, G., Galvan, O., de Vries, A., Ulmer, H., Gunkel, A., & Lukas, P. (2001). Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. European Journal of Cancer, 37(16), 2003–2009.

    Article  CAS  PubMed  Google Scholar 

  17. Sloan, J. A., Berk, L., Roscoe, J., et al. (2007). Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Journal of Clinical Oncology, 25(32), 5070–5077.

    Article  PubMed  Google Scholar 

  18. Delporte, C., O’Connell, B., Xinjun, H., et al. (1997). Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proceedings of the National Academy of Sciences USA, 94, 3268–3278.

    Article  CAS  Google Scholar 

  19. Lombaert, I., Wierenga, P., Kok, T., et al. (2006). Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clinical Cancer Research, 12, 1804–1812.

    Article  CAS  PubMed  Google Scholar 

  20. Sikorskii, A., Wyatt, G., Tamkus, D., Victorson, D., Rahbar, M., & Ahn, S. (2012). Concordance between patient reports of cancer-related symptoms and medical records documentation. Journal of Pain and Symptom Management, 44(3), 362–372.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This project was supported by Grants U10CA21661 (RTOG-Ops-Stat), U10CA180868 (NRG Oncology Operations), U10CA180822 (NRG Oncology SDMC), U10CA37422 (CCOP), UG1CA189867 (NCORP) from the National Cancer Institute (NCI).

Author’s contribution

Drs. Wyatt, Pugh, Wong, Sagar, Yom, and Berk were involved in conception and design. Drs. Wong, Sagar, Singh, Koyfman, Nguyen-Tân, Yom, Cardinale, Sultanem, Hodson, Krempl, Yeh, Berk, and Ms. Lukaszczyk acquired the data. Drs. Wyatt, Pugh, Wong, Sagar, Yom, and Berk analyzed and interpreted the data. Drs. Wyatt, Pugh, Wong, Sagar, Singh, Koyfman, Nguyen-Tân, Yom, Cardinale, Sultanem, Hodson, Krempl, Yeh, Berk, and Ms. Lukaszczyk drafted and revised the manuscript. Drs. Wyatt, Pugh, Wong, Sagar, Singh, Koyfman, Nguyen-Tân, Yom, Cardinale, Sultanem, Hodson, Krempl, Yeh, Berk, and Ms. Lukaszczyk approved the final version of the manuscript. All authors agree to be accountable for all aspects of the work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gwen Wyatt.

Ethics declarations

Conflict of interest

Dr. Singh reports that his institution has received per-case reimbursement from RTOG. Dr. Yom reports a research grant from Genentech, Inc. and royalties from UpToDate, Inc.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Appendix: The Head and Neck Symptom Scale of the University of Washington Quality of Life Questionnaire (UWHNSS)

Appendix: The Head and Neck Symptom Scale of the University of Washington Quality of Life Questionnaire (UWHNSS)

figure a
figure b

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wyatt, G., Pugh, S.L., Wong, R.K.W. et al. Xerostomia health-related quality of life: NRG oncology RTOG 0537. Qual Life Res 25, 2323–2333 (2016). https://doi.org/10.1007/s11136-016-1255-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-016-1255-0

Keywords

Navigation